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Abstract: 
Two new compounds, alternanthin B (1) and N-trans-feruloyl-3,5-dimethoxytyramine (2), along 
with four known compounds (3-6) were isolated from the aerial parts of Alternanthera 
philoxeroides. Their structures were elucidated on the basis of spectroscopic methods. The 
antitumor activity of the isolated compounds was also evaluated. 
 
Article: 
INTRODUCTION 
Alternanthera philoxeroides (Mart.) Griseb., is a folk medicinal herb widely distributed in Hubei, 
Hunan, Jiangsu and Zhejiang provinces of southern China, and has been used for the treatment of 
acute brain fever, measles and herpes zoster [1]. Pharmacological studies indicated that the 
extract of A. philoxeroides has antivirus, antibacterial, and molluscicidal activities 2-3. 
 
In our previous study, the EtOAc extract of A. philoxeroides revealed significant cytotoxic effect 
on Hela and L929 cell lines (97.24% and 84.75% at 200 μg/ml, respectively). Here we describe 
the structural elucidation of two new and four known compounds (1-6) (figure 1) from the 
EtOAc extract of A. philoxeroides, as well as their antitumor activities. 
 
 
Figure 1: The structures of compounds 1-6. 
RESULTS AND DISCUSSION 
Alternanthin B (1) was obtained as a yellow amorphous solid, exhibiting a quasi-molecular ion 
peak at m/z 417.1180 [M + H]+ by HRFTMS, indicating a molecular formula of C21H20O9 for 1. 
The UV spectrum of 1 showed a typical absorption of flavonoid at 271 and 335 nm. Its IR 
spectrum showed the presence of hydroxyl groups (3394 cm− 1) and a carbonyl carbon 
(1621 cm− 1). The 1H NMR spectrum of 1 showed an ABX spin system due to a 3′,4′-substitued 
benzyl group [δ 7.37 (br s), 6.94 (d, J = 8.5 Hz), 7.37 (br d, J = 8.5 Hz)], two olefinic protons [δ 
6.53 (s), 6.46 (s)], one acetal proton (δ 5.48, dd, J = 12.0, 2.3 Hz), and three oxygenated methine 
protons [δ 4.14 (q, J = 6.5 Hz), 4.00 (d, J = 2.8 Hz), 3.40 (d, J = 3.1 Hz)]. In addition to one 
methylene (δ 2.24, br t, J = 11.9 Hz, and 1.73, br d, J = 14.2 Hz) and one secondary methyl (δ 
1.28, d, J = 6.5 Hz). Its 13C NMR spectrum showed 21 carbons, including one carbonyl, nine 
olefinic quaternary carbons, five olefinic methines, one methyl, one methylene and four 
oxygenated methine carbon signals. From above observations, compound 1 was deduced to be a 
flavone glycoside, its 13C NMR spectral data was similar to those of alternanthin (3) [4], except 
for the absence of a methoxyl group (table 1). 
 
Table 1: 13C NMR spectral data of 1 and 3. 
Position 1 3 
2 166.5 165.1 
3 104.0 104.5 
4 184.1 183.4 
4a 105.1 105.1 
5 158.8 158.9 
6 111.7 111.9 
7 164.6 164.4 
8 96.1 96.0 
8a 158.4 157.7 
1′ 123.9 123.0 
2′ 114.4 110.7 
3′ 147.1 152.8 
4′ 151.1 149.4 
5′ 116.9 117.4 
6′ 120.5 121.8 
1″ 70.2 69.9 
2″ 33.0 33.7 
3″ 68.9 68.5 
4″ 70.8 70.6 
5″ 72.8 72.4 
6″ 17.4 18.2 
OCH3  – 56.5 
 
 
From 1H–1H COSY and HSQC spectra, a coupling system (H-1″ to H-6″) of the glycoside 
moiety was proposed. And its 1H and 13C NMR spectral data were also similar to the glycoside 
moiety of alternanthin (3) [4]. Thus, the glycoside moiety of 1 was elucidated as 2,6-dideoxy-
xylo-hexose. In the HMBC spectrum of 1, the proton signal at δ 5.48 (H-1″) correlated with the 
signals at δ 158.8 (C-5), 111.7 (C-6), and 164.6 (C-7), indicated the anomeric carbon of 
glycoside moiety was linked to C-6 through a C-linkage. And the chemical shift value of C-1″ (δ 
70.2) also supported this conclusion. Therefore, compound 1 was determined as luteolin 6-C-β-
L-boivinopyranoside. 
 
N-trans-feruloyl-3,5-dimethoxytyramine (2) revealed an ion peak at m/z 374.1598 [M + H]+, 
corresponding to a molecular formula of C20H23NO6. IR spectrum exhibited absorption bands 
for amide group (1657 and 1610 cm− 1). The 1H NMR spectrum of 2 revealed two methylene 
protons [δ 2.82(2H, t, J = 6.8 Hz), 3.62 (2H, q, J = 6.8 Hz)], three methoxyl protons [δ 3.87 (6H, 
s), 3.90 (3H, s)], two trans-olefinic protons [δ 6.19, 7.54 (each 1H, d, J = 15.5 Hz)], and an ABX 
pattern spin system due to a 3′,4′-substituted benzene [δ 6.97 (d, J = 1.8 Hz), 6.90 (d, J = 8.2 Hz) 
and 7.03 (dd, J = 8.2 and 1.8 Hz)], in addition to two olefinic protons at δ 6.44 (2H, s). Its 13C 
NMR spectrum showed 20 carbons, including one carbonyl carbon (δ 166.2), seven olefinic 
quaternary carbons, seven olefinic methines, two methylenes, and three methoxyl signals. 
Compound 2 was assumed to be a phenolic amide, its 13C NMR data were similar to those of 4 
[5], except for an additional methoxyl group. 
 
In the HMBC spectrum, the proton signal at δ 3.62 (H-1″) correlated with the signals at δ 166.2 
(C-1), 35.7 (C-2″) and 129.9 (C-1‴), the signal at δ 2.82 (H-2″) correlated with the signals at δ 
40.9 (C-1″), and 105.4 (C-2‴ and C-6‴), and the signal at δ 6.19 (H-2) correlated with the signals 
at δ 166.2 (C-1), 141.1 (C-3), and 127.2 (C-1′). Furthermore, the methoxyl signals at δ 3.87 (6H, 
s) showed the NOE correlation with the signals at δ 6.44 (H-2‴ and 6‴), another methoxyl signal 
at δ 3.90 (3H, s) correlated with the signal at δ 6.97 (H-2′). Therefore, the structure of 3 was 
determined as N-trans-feruloyl-3,5-dimethoxytyramine. 
 
Four known compounds were identified by their spectroscopic data in comparison with literature 
values as follows: alternanthin (3) [4], N-trans-feruloyl-3-methyldopamine (4) [5] N-trans-
feruloyl tyramine (5) [5], and N-cis-feruloyl tyramine (6) [6]. 
 
In a search for antitumor active substances, we examined the inhibitory effect of compounds 1-5 
on Hela and L929 cell lines, respectively. Compounds 2-5 showed significant inhibitory effects 
on Hela cell growth (table 3). 
 
 
Table 2: 1H NMR and 13C NMR spectral data of 2. 
Position 1H 13C 
Feruloyl   
1 – 166.2 
2 6.19 d J = 15.5 Hz 118.1 
3 7.54 d J = 15.5 Hz 141.1 
1′ – 127.2 
2′ 6.97 d J = 1.8 Hz 109.5 
3′ – 146.7 
4′ – 147.4 
5′ 6.90 d J = 8.2 Hz 114.7 
6′ 7.03 d J = 1.8, 8.2 Hz 122.1 
OCH3  3.90 s (3H) 55.9 
Amine   
1″ 3.62 q (2H) J = 6.8 Hz 40.9 
2″ 2.82 d (2H) J = 6.8 Hz 35.7 
1‴ – 129.9 
2‴ 6.44 s 105.4 
3‴ – 147.1 
4‴ – 133.3 
5‴ – 147.1 
6‴ 6.44 s 105.4 
OCH3 × 2 3.87 s (6H) 56.3 
 
 
  
Table 3: Inhibitory activity of 1-5 against Hela and L929 a. 
  Inhibition (%) 
  Hela  L929 
Compounds 30 μg/ml 10 μg/ml  30 μg/ml 10 μg/ml 
1  26.5 8.9  50.3 22.6 
2  72.1 40.7  32.0 − 0.7 
3  55.9 49.0  74.9 − 9.4 
4  58.2 28.9  13.2 4.0 
5  72.2 52.9  22.0 2.0 
 
a (P < 0.05, n = 6) 
 
 
EXPERIMENTAL 
General experimental procedures 
NMR spectra were run on a Bruker AVANCE 300 instrument with TMS as internal standard. 
HRFTMS and ESIMS were obtained on IonSpec 4.7 Tesla FTMS and Alliance 2695 Quattro 
Micro TM ESI (Waters) instrument, respectively. Column chromatography was performed on 
silica-gel (Qingdao Haiyang Chemical Co., Ltd), Sephadex LH-20 (Amersham Pharmacia 
Biotech) and Toyopearl HW-40 (TOSOH). Flash chromatography was carried on a column (C18 
HS 40M 1621-1, Biotage, Inc. USA). HPLC was a JASCO Gulliver Series with PU-1580 
(pump), RI-1530 and UV-1575 (detector). Semi-Preparative HPLC column was used as below: 
ODS (YMC-Pack ODS-A, SH-343-5). IR spectra were recorded on a NICOLET 380 FT-IR 
spectrophotometer (Thermo Electron Corporation). UV spectra were taken on a Shimadzu UV-
240 spectrophotometer. Optical rotation was measured with a MC 241 digital polarimeter 
(PERKIN-ELMER). 
 
Plant material 
The aerial parts of Alternanthera philoxeroides (Mart.) Griseb were collected in Wuhan, Hubei 
province of China in November 2003 and identified by Prof. Ding-Rong Wan (School of Life 
Sciences, South-Central University for Nationalities). A voucher specimen (D20030802) has 
been deposited at School of Pharmacy, Tianjin Medical University, China. 
 
Extraction and isolation 
The dried aerial parts (9.0 kg) of A. philoxeroides were crushed and extracted three times with 
EtOH (95%, 60 L each) under reflux for 6 hours. The EtOH extract was concentrated in vacuo to 
give a residue (960 g), which was suspended in H2O, and then partitioned with petroleum ether, 
EtOAc and n-BuOH, successively. The EtOAc extract (53 g) was chromatographed on silica gel 
column eluting with solvents of increasing polarity [petroleum ether—EtOAc (3:1, 2:1, 1:1, 1:2, 
1:3, 100%EtOAc, EtOAc-5% MeOH, EtOAc-10%MeOH, EtOAc-20%MeOH, 100%MeOH)] to 
yield 22 fractions. Fraction 12 (4.0 g) was rechromatographed on silica gel column (CHCl3-
MeOH, 95:5, then 9:1) to give 11 fractions (fr.12.1-12.11). Fraction 12.8 (0.7 g) was 
chromatographed on Toyopearl HW-40 (CHCl3/MeOH, 2:1) and then flash chromatography 
(C18, MeOH: H2O: HAc 50: 49: 1) to give 5 (89 mg) and 6 (25 mg). Fraction 12.9 (150 mg) was 
chromatographed on Toyopearl HW-40 (CHCl3/MeOH, 2:1) to give 3 (64 mg). Fraction 15 
(4.3 g) was rechromatographed on silica gel column (CHCl3-MeOH, 95:5, 9:1, 8:2) to give ten 
fractions (fr.15.1-15.10). Fraction 15.3 (550 mg) was chromatographed on Toyopearl HW-40 
and then preparative TLC to give 2 (18 mg) and 4 (15 mg). Fraction 15.5 (98 mg) was separated 
by HPLC (ODS-A, MeOH/H2O, 7:3) to give 1 (24 mg). 
 
Alternanthin B (1). Yellow amorphous solid. [α]D 25+86.9 (c 0.29, MeOH). UV nm 
(log ϵ): 271 (4.02), 335 (4.14). IR (KBr) νmax cm− 1: 3394, 2924, 2855, 1621, 1574, 1487, 1454, 
1367, 1296, 1271, 1207, 1170, 1118, 1057. 1H NMR (CD3OD) δ 6.53 (1H, s, H-3), 6.46 (1H, s, 
H-8), 7.37 (1H, br s, H-2′), 6.94 (1H, d, J = 8.5 Hz, H-5′), 7.37 (1H, br d, J = 8.5 Hz, H-6′), 5.48 
(1H, dd, J = 12.0 Hz, 2.3 Hz, H-1″), 1.73 (1H, br d, J = 14.2 Hz, H-2a), 2.24 (1H, br t, 
J = 11.9 Hz, H-2e), 4.00 (1H, d, J = 2.8 Hz, H-3″), 3.40 (1H, d, J = 3.1 Hz, H-4″), 4.14 (1H, q, 
J = 6.5 Hz, H-5″), 1.28 (3H, d, J = 6.5 Hz, H3-6″). 13C NMR (CD3OD) data were listed in Table 
1. ESI-MS: m/z 415[M − H]− . HRFTMS (MALDI-DHB) m/z 417.1180 [M + H]+ (calcd for 
C21H21O9, 417.1179). 
 
N-trans-feruloyl-3,5-dimethoxytyramine (2). Yellow solid. [α]D 25 − 18.0 (c 0.68, MeOH). UV 
nm (log ϵ): 232 (4.13), 295 (3.98), 319 (4.09). IR (KBr) νmax cm− 1: 3387, 2934, 2847, 
1657, 1610, 1517, 1460, 1428, 1365, 1330, 1275, 1216, 1160, 1118, 1033, 980, 820. ESI-MS: 
m/z 372 [M − H]− . HRFTMS (MALDI-DHB) m/z 374.1598 [M + H]+ (calcd for C20H24NO6, 
374.1600). 1H NMR and 13C NMR (CDCl3) data were listed in table 2. 
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